CROUSDT
Crypto.com Coin / Tether USD
crypto Composite

If you are happy with your bag then trading your earned CRO for BTC is prudent, and a good way to dollar cost average into BTC.
Not a certainty that CRO will recover relative to BTC, and if it did you will benefit enough from the appreciation of the principal.
Keeping the earned interest in CRO when you already are happy with the amount of CRO you have would just be over allocating to CRO.
All my opinion, you are of course responsible for your own decisions here.

Additional coins sir. If my goal was 1,000,000 CRO then any “free” CRO I earn I’ll swap

The real question is do you want to hold $7k worth of CRO, the cards are a great use case of CRO you hold, they're not good enough to buy CRO specifically to use them.

Not CRO holders I guess 😂

Long-term Icy White holder here...
Before investing $7k AUD for the card, do you think CRO will go UP or Down in value? At its current price of $0.056, its a lot more likely to go up, than if you paid $7k when it was $0.1 and watched your investment go down by almost 50%. Even if you maxed out your rewards, losing 50% of your investment is a major loss compared to the rewards you might have gained.
On the other hand, if you invest $7k and it goes up to $0.1 now, you can nearly double your investment, and all your rewards are doubled in value on the way up.
It really is a gamble. Can you afford to lose your initial investment if it goes down, and your rewards don't mean anything in the long run... or bet that it will go up and get more than what you paid for?
For me and most Icy White/Rose Gold holders, we're down over 50-70% of our investment for the card in the last year due to CRO dropping in price.

There's not one person there smiling because they're holding CRO.
CDC has abandoned it's exchange token just to be used by new investors and then inflated which makes its price go down.

I bought in at the ATH season of Nov 2021 just before it all crumbled. I went hard and invested heavy and had lots in Loopring, CRO, SAND, LUNA, MANA, etc. Only to watch red downward lines become my new daily nightmare haha.
At this point I deserve a government bail out.

Ill tell you what, friend. I was a believer for CRO too. I had north of 690K+ in cro token. Hold cro was like a toxic relationship haha. So much ups and down. I accumulate since 2022, held through ftx collapse then finally sold after the promise “Uptober” that never happened. Literally went round trip barely made any profit.
The main reason I left was the vote to unburn token in march. The majority of the non-crypto.com node vote no, but that does matter because CDC had 4-5 node of their own with like 60%+ voting power. The unburn doesnt affect the circulation tolen, yes but the community doesnt want it. So without a solid community any crypto will just die and in this case the leadership decision 100% broke the community. I mean just look at this sub now so quiet, full of despair. The active optimistic users feel inorganic and like CDC paid them to keep this sub alive. Just a tin foil thought. Anyways, I held on until after uptober was due to the whole crypto sentiment, greed and glimmer of hope.
But…yea huge disappointment and im glad i left. Just once in a while drop in r/cro to see the sentiment and a reminder that I have made a good decision to sell.

Nae gains for CRO though! Fucking shitcoin!

They brought a new CEO, and executive team in a short while back as head of Cronos Labs, this includes the Exchange and the DeFi platforms, but doesn’t include the main CDC App. The Cronos Lab group is mainly responsible for CRO(the native crypto) and improvements across the Exchange & DeFi. This new “Super App” is purportedly a vast improvement on the current platform, and being built around GenX. For me, I’m more pleased that they’re looking to improve, I use all 3 platforms that CDC provides, each one of them has its advantages.
This has nothing to do with price or recommending something to buy, it’s merely an alternative to the other platforms mentioned within this thread. It’s easy to check on Google etc what CDC is doing, and intending to release.

Not much party here in the CRO community 🤗

So you have the icy white/rose gold card and are staking 45.000 in CRO?
Was that really worth it for you, considering the token losing 30% value in the last 12 months?

i will hod till CRO reaches 1000

# 4. The Numbers: What Management Says vs. What the Balance Sheet Shows
# Income Statement (from earnings call transcripts)
|Metric|FY2024|FY2025|YoY|
|:-|:-|:-|:-|
|Revenue|RMB 5.80B|RMB 6.22B|\+7.3%|
|Net Income|RMB 1.06B|RMB 1.54B|\+44.8%|
|Net Margin|18.2%|24.6%|\+6.4pp|
|Facilitation Volume|\~RMB 101B|RMB 129B|\+28%|
**Superficially, this looks great.** Revenue up 7%, net income up 45%, margins expanding. This is the "value stock" thesis.
# Quarterly Trend (the real story)
|Q1 2025|Q2 2025|Q3 2025|Q4 2025|
|:-|:-|:-|:-|
|Revenue (RMB M)|1,776|1,886|1,470|1,090|
|QoQ Rev Growth|—|\+6.2%|**-22.1%**|**-25.8%**|
|Net Income (RMB M)|540|519|371|101|
|Net Margin|30.4%|27.5%|25.2%|**9.2%**|
|Facilitation Vol (RMB B)|35.6|37.1|32.2|24.2|
|90+ Day Delinquency|1.13%|1.12%|1.33%|**2.03%**|
|Non-GAAP Op Income (RMB M)|607|738|491|120|
**The quarterly trend is catastrophic.** Revenue fell 38% from Q2 peak to Q4. Net income collapsed 81%. Facilitation volume dropped 35%. Delinquency nearly doubled. Q1 2026 guidance is RMB 18.5-19.5B in facilitation volume — **another \~22% decline from Q4 2025.**
# Balance Sheet (Q4 2024 → Q4 2025)
|Line Item|Q4 2024|Q4 2025|Change|
|:-|:-|:-|:-|
|Cash|RMB 541M|**RMB 62M**|**-89%**|
|Receivables|RMB 3.49B|RMB 5.23B|\+50%|
|PP&E|RMB 97M|**RMB 1.36B**|**+1,297%**|
|Total Debt|RMB 52M|RMB 701M|\+1,255%|
|Total Assets|RMB 5.41B|RMB 8.76B|\+62%|
|Total Liabilities|RMB 2.28B|RMB 4.32B|\+89%|
|Equity|RMB 3.13B|RMB 4.43B|\+42%|
**The balance sheet tells a completely different story from the income statement.**
# 5. Red Flags — Ranked by Severity
# CRITICAL: Cash Evaporated Despite "Record" Profits
JFIN reported RMB 1.53B in net income for FY2025. Yet cash dropped from RMB 541M to RMB 62M — a decrease of RMB 479M. Where did the money go?
* **Capex: RMB 635M** — For a fintech platform, 10.2% capex/revenue is extreme. In FY2023, capex was only RMB 32M. In FY2024, it was RMB 739M. What exactly are they building that costs this much?
* **Investing cash outflow: RMB 1.95B** — This includes RMB 1.16B in "other investing activities" — a black box.
* **Net debt issuance: RMB 706M** — The company borrowed heavily while burning cash.
* **Shareholder returns: \~RMB 327M** — $41.1M dividends + $30.4M buybacks. Taking cash out of a company whose cash position is collapsing.
**Bottom line:** If you report RMB 1.53B in profit but your cash drops by RMB 479M, either (a) you're investing heavily for growth (the capex story), or (b) the profits aren't real. The PP&E explosion suggests (a) but the nature of the investments raises questions.
# CRITICAL: PP&E Exploded from RMB 97M to RMB 1.36B
A fintech company with 1,028 employees does not need RMB 1.36B in property, plant, and equipment. For comparison:
* FY2021: RMB 45M
* FY2022: RMB 47M
* FY2023: RMB 90M
* FY2024: RMB 97M
* **FY2025: RMB 1,358M**
This is 14x growth in one year. The company is either:
1. Capitalizing software development costs aggressively (shifting expenses from the income statement to the balance sheet to inflate profits)
2. Making genuine investments in data centers or other hard assets (unlikely at this scale for a loan-matching platform)
3. Using PPE as a vehicle to move cash somewhere — potentially to related parties
**The Q2 2025 transcript mentions "Fuxi model management platform" and "Tianlu R&D performance management platform" — these sound like capitalized software, not hard assets.** If R&D is being capitalized into PP&E, reported profits are overstated by exactly the amount of the capitalization.
# CRITICAL: Receivables Growing Faster Than Revenue
Receivables grew from RMB 3.49B to RMB 5.23B (+50%) while revenue grew only 7.3%. This means:
* **DSO (Days Sales Outstanding):** Each RMB of revenue is taking longer to collect
* Receivables / Revenue = 0.84x (FY2024: 0.60x)
* The company is booking revenue that hasn't been collected in cash — common in fintech, but the trend is deteriorating
Combined with rising delinquency rates, the quality of these receivables is highly suspect.
# HIGH: Cash/Current Liabilities = 0.017
JFIN has RMB 62M in cash against RMB 3.68B in current liabilities. That's 1.7 cents of cash for every dollar of short-term obligations. In FY2024, this ratio was 0.27. The company is **effectively insolvent on a cash basis** and depends entirely on:
* Collecting receivables (which are growing and deteriorating in quality)
* Rolling over short-term debt
* Access to institutional funding lines
# HIGH: 90+ Day Delinquency Doubled
From 1.13% (Q1 2025) to 2.03% (Q4 2025). The CRO attributed this to "new regulation implementation" and "industry-wide risk cycle." She said risk metrics improved \~25-30% from their management interventions.
But 2.03% at 90+ days is a **lagging indicator.** The loans delinquent at 90+ days in Q4 were originated months earlier. The QoQ trend (1.12% → 1.33% → 2.03%) shows acceleration, not stabilization.
# HIGH: Prior Material Weaknesses + Auditor Change
Marcum found material weaknesses in 2021 and 2022. These were "remediated" by the time Deloitte took over, but the fact pattern (material weakness → remediation → switch to Big 4) is a known pre-fraud pattern.
# MODERATE: New CRO Just Appointed
Dan Qi replaced Yifang Xu as Chief Risk Officer, effective June 1, 2026. Xu stays on the board. A CRO change when risk metrics are deteriorating is either (a) accountability for poor risk management, or (b) the outgoing CRO seeing something they don't want to sign off on. The "personal reasons" explanation and board retention suggests (a), but the timing is notable.
# MODERATE: Q4 2025 Revenue Recognition Changes
The Q4 2025 transcript mentions a RMB 20.1M "reversal of credit losses" — i.e., they wrote BACK prior loan-loss provisions, which boosted Q4 income. Without this reversal, Q4 would have been even worse. Reversing loan-loss provisions when delinquencies are rising is aggressive accounting.
# MODERATE: FMP Structured Data vs. Transcript Discrepancy
FMP's income statement for FY2025 shows revenue of RMB 866M (vs. RMB 6.22B from transcripts) and net income of RMB 214M (vs. RMB 1.54B). While this is likely an FMP data parsing issue (the company uses "net revenue" differently and FMP may not capture all line items correctly for Chinese fintech companies), the magnitude of the discrepancy (7x on revenue, 7x on net income) means external data users cannot verify the company's reported numbers through standard APIs.
# 6. The Bull Case (Why Someone Calls This a "Value Stock")
* **P/E of \~0.2x** (on management's numbers) — absurdly cheap
* **P/B of 0.08x** — trading at 8% of book value
* **5.2% dividend yield** (though sustainability is questionable)
* **Deloitte audit** — Big 4 auditor provides some assurance
* **Revenue still grew 7.3%** for the full year (even if Q4 was bad)
* **New regulations** could drive industry consolidation, benefiting survivors
* **International expansion** — Indonesia +187% volume growth, Mexico +105%
* **$50M remaining buyback authorization** — management buying stock signals confidence
The value thesis rests entirely on: (a) the reported numbers are real, and (b) the Q4 collapse is a temporary regulatory adjustment, not a structural decline. If both are true, this is the cheapest stock in the market.

Problem is when CRO is .10 again, Bitcoin will probably be $150k…

Give me 2 weeks as CRO CEO and I’ll change the direction

No se amigo, estoy en la misma duda, mi bloqueo termina en agosto-septiembre y estoy pensando seriamente en vender a perdida porque veo que crypto.com no está haciendo nada por CRO, ojalá en estos casi 3 meses que me quedan se vea algo bueno para CRO porque si no terminaré vendiendo, bloqueando y quemando todo antecedente de Crypto.com en relación a mi persona, la decepción es MUY GRANDE.

I’ve stacked up a bag I’m “happy” with. I’ve thought maybe now I’ll start selling any earned CRO for BTC.
However. How could I sell now? We’re in the low of lows. Surely we have a few good bull runs left, I should hold the CRO I want to sell for when we are over .10 again right? RIGHT?!

CRO Visa Prepaid Card Worth It?